Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden
This article was originally published in The Tan Sheet
Executive Summary
Schiff Nutrition International makes a $40 million investment in probiotic supplements by acquiring worldwide exclusive rights to the GanedenBC30 strain and a pair of consumer probiotics brands.
You may also be interested in...
Sales & Earnings In Brief
Sensodyne innovation aids Glaxo consumer
People In Brief
Schiff Nutrition welcomes Steeves-Kiss
Ingredient Supplier Interest In Functional Foods Shows No Sign Of Let-Up
Market research firm Mintel says the consumer market for functional foods and beverages has hit a lull, but at the product development level the segment continues expanding with new ingredients and applications.